Endorectal Balloon Market
The advantages of the endorectal balloon have been proved in a number of investigations in both 3D conformal radiotherapy (3D-CRT) and Intensity Modulated Radiotherapy (IMRT) for primary prostate irradiation, and postoperative prostatic-bed irradiation. More recent research is showing that the ERB can also be used to spare the rectal wall and anal wall during radiation treatment for cervical, bladder and endometrial cancer. The non-latex endorectal balloon is inflated in order to gently move the posterior rectal wall away from the prostate and the high irradiation dose region. This results in considerable dose reduction to the rectal and anal wall mucosa, as well as the anal sphincter. The ERB is well tolerated in over 95% of patients and enables quick and easy insertion and removal by therapists at the treatment machine. The ERB is a flexible, single-use device specifically designed for daily rectal placement prior to treatment delivery.
Read Report Overview – https://www.transparencymarketresearch.com/endorectal-balloon-marke...
Endorectal balloons may be of benefit during stereotactic body radiation therapy of the prostate to limit intrafraction prostatic motion and potentially minimize rectal toxicity. The design of ERB not only addresses patient comfort, but also simplifies three challenging clinical scenarios that many physicians face when using radiation therapy for and/or in relation to the prostate. First, its gas-release tip removes rectal gas and reduces prostate motion for gaseous patients. Secondly, the structure of the ERB aids in defining the anatomy for difficult planning scenarios with post-radical patients. Lastly, it repositions and lifts the bowel in patients that have a low-lying bowel.
Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B...
Endorectal Balloon Market- Introduction
Endorectal balloons are a single use, non-powered inflatable device placed in the rectum to immobilize the prostate in patients undergoing radiation therapy. These balloons are made of silicon or polyurethane material. Endorectal balloons minimize the challenges faced by physicians during the radiation therapy. Endorectal balloons are quick and easy to insert and remove by the therapist during the treatment. It is well tolerated in over 95% of patients. Single use balloons are used to reduce ano-rectal toxicity. Moreover, endorectal balloons are used in the treatment of prostate malignancies. Endorectal balloons offer protection against rectal complications from prostate cancer. Additionally, these balloons are used to spare the anal and rectal wall during the treatment of endometrial, bladder, and cervical cancer. The endorectal balloon advantage has been proven in intensity modulated radiotherapy and 3 dimensional conformal radiotherapy for post-operative prostatic bed irradiation and prostate irradiation.
Request COVID Analysis on Endorectal Balloon Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=c...
Endorectal Balloon Market – Competitive Landscape
The global endorectal balloon market is highly fragmented due to the presence of large number of players. Numerous manufacturers hold prominent market shares in their respective regions. Leading players in the global endorectal balloon market are QLRAD, AngioDynamics, Klarity Medical Products, Bionix, and RadiaDyne among other prominent players. These players are engaged in developing new technologies and strategies. Key developments by these prominent players are likely to propel the growth of the endorectal balloon market. For instance, in September 2018, AngioDynamics signed an agreement to acquire RadiaDyne and its radiation dose monitoring platform. This acquisition enabled the company to expand its oncology business portfolio. Demand for endorectal balloons has increased due to increase in prevalence of prostate cancer. Industry players are adopting practices of appointing third-party distributors to expand market presence. For instance, NL-Tec is a supplier of solutions for oncology in New Zealand and Australia. It supplies RectalPro and RectalPro 65 endorectal balloon products manufactured by QLRAD
Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=E...
QLRAD
QLRAD is one of the leading players operating in the endorectal balloon market. The company is engaged in developing, designing, and manufacturing radiotherapy accessories and urology devices such as endorectal balloons and fiducial gold markers. Additionally, the company supplies products for urology, radiology, and radiotherapy across the world. QLRAD operates in two segments namely, radiotherapy and urology. Radiotherapy segment offers endorectal balloons.
AngioDynamics
AngioDynamics is a well-established player and the company was founded in 1988. It is engaged in developing disruptive and differentiated technologies for healthcare providers. The company offers products for acute and chronic diseases in peripheral vascular, and oncology medicine.
Klarity Medical Products
Klarity Medical Products manufactures and distributes products serving needs of occupational therapies, radiation therapies, and hand therapies. The company has manufacturing and distribution facilities in the U.S., Europe, and China
Endorectal Balloon Market – Dynamics
Increase in demand for endorectal balloons
Increasing prevalence of prostate cancer is driving the demand for endorectal balloons. According to American Institute for Cancer Research, prostate cancer is the second most common cancer in men across the world and an estimated 1.3 million new cases was recorded in 2018. Moreover, advantage over conventional methods is one of the factors likely to fuel the growth of the endorectal balloon market.
Technological advancement
Technological advancement in products for the treatment of prostate cancer is likely to propel the growth of the endorectal balloon market. For instance, radiation treatment such as three dimensional conformal radiation therapy (3DCRT), proton therapy (PT), and intensity modulated radiotherapy (IMR) are technologically advanced therapies for prostate cancer radiotherapy
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/